Virani Shafique
SEC CIK 1856081 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Chief Corp. Dev. Off | 154.7K | — | $4.21M | 44 | 2022-02-04 | 2024-01-16 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Virani Shafique made no open-market trades at RXRX in the last 12 months.
Transactions 44
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-18 | 2024-01-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 154.7K | +13% | +$40.0K |
| D | 2024-01-18 | 2024-01-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $10.93 | -18.0K | 136.7K | -12% | -$196.7K |
| D | 2023-12-19 | 2023-12-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $9.60 | -18.0K | 136.7K | -12% | -$172.8K |
| D | 2023-12-19 | 2023-12-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 154.7K | +13% | +$40.0K |
| D | 2023-11-17 | 2023-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 158.4K | +13% | +$40.0K |
| D | 2023-11-17 | 2023-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $6.51 | -18.0K | 140.4K | -11% | -$117.2K |
| D | 2023-11-17 | 2023-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $7.18 | -3,603 | 136.7K | -3% | -$25.9K |
| D | 2023-10-18 | 2023-10-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 158.4K | +13% | +$40.0K |
| D | 2023-10-18 | 2023-10-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $6.30 | -18.0K | 140.4K | -11% | -$113.4K |
| D | 2023-09-19 | 2023-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 158.4K | +13% | +$40.0K |
| D | 2023-09-19 | 2023-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $8.66 | -18.0K | 140.4K | -11% | -$155.9K |
| D | 2023-08-17 | 2023-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $9.19 | -3,603 | 140.4K | -3% | -$33.1K |
| D | 2023-08-17 | 2023-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $9.25 | -18.0K | 140.4K | -11% | -$166.5K |
| D | 2023-08-17 | 2023-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +18.0K | 158.4K | +13% | +$40.0K |
| DM | 2023-07-27 | 2023-07-25+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +40.0K | 164.0K | +32% | +$88.8K |
| DM | 2023-07-27 | 2023-07-25+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $14.36 | -40.0K | 144.0K | -22% | -$574.2K |
| DM | 2023-07-19 | 2023-07-17+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $12.73 | -60.0K | 144.0K | -29% | -$763.8K |
| DM | 2023-07-19 | 2023-07-17+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +60.0K | 174.0K | +53% | +$133.2K |
| DM | 2023-06-20 | 2023-06-15+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +60.0K | 174.0K | +53% | +$133.2K |
| DM | 2023-06-20 | 2023-06-15+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $9.54 | -60.0K | 144.0K | -29% | -$572.4K |
| M | 2023-06-05 | 2023-06-01+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale | $8.73 | -42.9K | 161.8K | -21% | -$374.0K |
| 2023-05-17 | 2023-05-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $5.60 | -2,230 | 185.1K | -1% | -$12.5K | |
| D | 2023-02-17 | 2023-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $8.44 | -746 | 189.1K | -0.4% | -$6,296 |
| DM | 2023-02-17 | 2023-02-15+ | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $8.35 | -9,254 | 189.8K | -5% | -$77.2K |
| D | 2023-02-17 | 2023-02-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +7,486 | 197.3K | +4% | +$16.6K |
| DM | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | A - Grant | $0.00 | +117.1K | 192.8K | +155% | $0 |
| D | 2023-02-03 | 2023-02-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $8.55 | -2,994 | 189.8K | -2% | -$25.6K |
| D | 2023-01-19 | 2023-01-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $9.16 | -10.0K | 73.2K | -12% | -$91.6K |
| D | 2023-01-19 | 2023-01-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +5,000 | 83.2K | +6% | +$11.1K |
| D | 2022-12-19 | 2022-12-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $8.85 | -10.0K | 78.2K | -11% | -$88.5K |
| D | 2022-12-19 | 2022-12-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +5,000 | 88.2K | +6% | +$11.1K |
| D | 2022-11-17 | 2022-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $11.86 | -613 | 88.2K | -0.7% | -$7,270 |
| D | 2022-11-17 | 2022-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +5,000 | 93.2K | +6% | +$11.1K |
| DM | 2022-11-17 | 2022-11-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $12.31 | -10.0K | 83.2K | -11% | -$123.1K |
| D | 2022-10-18 | 2022-10-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +5,000 | 98.8K | +5% | +$11.1K |
| DM | 2022-10-18 | 2022-10-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $10.92 | -10.0K | 88.8K | -10% | -$109.2K |
| DM | 2022-09-16 | 2022-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $13.37 | -10.0K | 94.2K | -10% | -$133.7K |
| D | 2022-09-16 | 2022-09-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +5,000 | 103.8K | +5% | +$11.1K |
| D | 2022-08-17 | 2022-08-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | F - Tax | $12.96 | -613 | 103.8K | -0.6% | -$7,944 |
| D | 2022-08-17 | 2022-08-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | M - OptEx | $2.22 | +25.0K | 128.8K | +24% | +$55.5K |
| D | 2022-08-17 | 2022-08-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Business Off | S - Sale+OE | $12.61 | -30.0K | 98.8K | -23% | -$378.3K |
| 2022-05-18 | 2022-05-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Corp. Dev. Off | F - Tax | $5.67 | -870 | 104.4K | -0.8% | -$4,933 | |
| DM | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Corp. Dev. Off | A - Grant | $0.00 | +42.9K | 103.7K | +71% | $0 |
| D | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Virani Shafique | Chief Corp. Dev. Off | F - Tax | $11.40 | -1,114 | 105.3K | -1% | -$12.7K |
Purchase Sale Sale after option exercise All abbreviations